David Becker, MD, FACC, Director of the Preventive and Integrative Heart Health Program at the Temple Heart and Vascular Institute, wrote a blog post for the Philadelphia Inquirer about the medication Vascepa.
800-TEMPLE-MED
Request Appointment
SEARCH TEMPLE HEALTH
Related News
Dr. Anjali Vaidya Provides Perspective to Healio on FDA Label Update for Winrevair
Posted October 2, 2026
The update for Winrevair includes that it lowers the risk for clinical worsening events in adults with recently diagnosed pulmonary arterial hypertension.
View Details